FinanceCity
HealthcareNSE · BSE

Neuland Laboratories Limited.

NEULANDLAB · ISIN INE794A01010

Share price

₹16,688 -2.16%

Market capitalisation

₹21411 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹21411 Cr

Current price

₹16,688

-2.16% today

52W high

₹19,747

52W low

₹11,500

Stock P/E

58.94

P/B ratio

11.43

02 · Per share & returns

EPS (TTM)

₹283

Book value

₹1,460

ROE

ROA

Dividend yield

0.20%

Beta

-0.32

03 · Financials (TTM)

By the numbers

Revenue

₹606 Cr

+136.40% YoY

EBITDA

₹53.42 Cr

Net profit

₹13.86 Cr

+664.40% YoY

Profit margin

2.29%

Operating margin

36.36%

Total debt

₹301 Cr

Total cash

₹355 Cr

Debt / equity

0.16x

Current ratio

1.42x

Payout ratio

4.23%

04 · Analyst view

Target price

₹20,972

Upside

+25.67%

Consensus

STRONG BUY

Analysts

4

05 · Shareholding pattern

Who owns NEULANDLAB?

  • Promoters

    32.63%

    Founders & promoter group

  • Institutions

    27.19%

    FII + DII

  • Public

    40.18%

    Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol
NEULANDLAB
Exchange
NSE · BSE
CIN
ISIN
INE794A01010
BSE code
524558
Sector
Healthcare
Industry
Healthcare
Face value
₹10
Listing date
12 Oct 2008
Employees
Headquarters
Hyderabad, India

07 · About

What is Neuland Laboratories Limited.?

Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

08 · Common questions

Frequently asked

What is the CIN of Neuland Laboratories Limited.?+

The Corporate Identity Number for Neuland Laboratories Limited. is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Neuland Laboratories Limited.?+

Promoter holding in NEULANDLAB is approximately 32.63%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Neuland Laboratories Limited.?+

Neuland Laboratories Limited. (NEULANDLAB) has a market capitalisation of approximately ₹21411 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →